BVI 📈 Bureau Veritas SA - Overview
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0006174348
BVI: Laboratory Testing, Inspection, Certification, Auditing, Compliance Reports
Bureau Veritas SA is a global leader in providing laboratory testing, inspection, and certification services, operating through a diverse range of segments including Marine & Offshore, Agri-Food & Commodities, Buildings & Infrastructure, Industry, Certification, and Consumer Products. This multifaceted approach enables the company to cater to a wide array of industries, including automotive and transportation, building and infrastructure, chemicals, and consumer products, among others. By offering a comprehensive suite of services, Bureau Veritas helps its clients ensure compliance with regulatory standards, enhance product quality, and improve operational efficiency.
The company's service portfolio is extensive, encompassing laboratory and on-site testing, inspection services for products and assets, and certification services for management systems, products, and individuals. These services are designed to help clients verify quantity, control quality, and meet stringent regulatory requirements. With a strong presence in approximately 140 countries, Bureau Veritas boasts an impressive network of offices and laboratories, facilitating the delivery of its services to a global clientele. This widespread reach is a testament to the company's commitment to supporting businesses across various sectors, including financial services and public sectors.
Founded in 1828, Bureau Veritas SA has a rich history spanning nearly two centuries, with its headquarters located in Neuilly-sur-Seine, France. As a publicly traded company, its common stock is listed under the ISIN code FR0006174348, and it is classified under the GICS Sub Industry of Research & Consulting Services. With a strong online presence, the company's website, https://group.bureauveritas.com, serves as a valuable resource for clients and investors seeking information on its services, operations, and financial performance. Through its dedication to quality, compliance, and innovation, Bureau Veritas has established itself as a trusted partner for businesses seeking to navigate complex regulatory landscapes and achieve operational excellence.
Additional Sources for BVI Stock
BVI Stock Overview
Market Cap in USD | 13,912m |
Sector | Industrials |
Industry | Consulting Services |
GiC Sub-Industry | Research & Consulting Services |
IPO / Inception | 2007-10-24 |
BVI Stock Ratings
Growth 5y | 47.1% |
Fundamental | 65.5% |
Dividend | 60.0% |
Rel. Strength Industry | 99.7 |
Analysts | - |
Fair Price Momentum | 30.32 EUR |
Fair Price DCF | 58.45 EUR |
BVI Dividends
Dividend Yield 12m | 2.83% |
Yield on Cost 5y | 3.86% |
Annual Growth 5y | 6.58% |
Payout Consistency | 87.6% |
BVI Growth Ratios
Growth Correlation 3m | -21% |
Growth Correlation 12m | 84.5% |
Growth Correlation 5y | 68.4% |
CAGR 5y | 5.88% |
CAGR/Mean DD 5y | 0.50 |
Sharpe Ratio 12m | 1.15 |
Alpha | 11.87 |
Beta | 0.62 |
Volatility | 17.54% |
Current Volume | 5593.3k |
Average Volume 20d | 1052.8k |
As of December 21, 2024, the stock is trading at EUR 28.78 with a total of 5,593,311 shares traded.
Over the past week, the price has changed by -2.59%, over one month by +4.78%, over three months by -1.14% and over the past year by +35.78%.
Yes, based on ValueRay Fundamental Analyses, Bureau Veritas SA (PA:BVI) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 65.51 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BVI as of December 2024 is 30.32. This means that BVI is currently overvalued and has a potential downside of 5.35%.
Bureau Veritas SA has no consensus analysts rating.
According to ValueRays Forecast Model, BVI Bureau Veritas SA will be worth about 33 in December 2025. The stock is currently trading at 28.78. This means that the stock has a potential upside of +14.77%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 33 | 14.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 33 | 14.8% |